SCHEMBL7387679

SCHEMBL7387679

C=CCN(CCc1ccccc1)C(=O)/C=C/C=C/C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
RAB9A P51151 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TAAR1 Q96RJ0 2/20 0.39
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALOX5 P09917 1/20 0.38
LTB4R Q15722 1/20 0.38
LTB4R2 Q9NPC1 1/20 0.38
BCHE P06276 2/20 0.37
RCE1 Q9Y256 1/20 0.36
OPRM1 P35372 3/20 0.36
OPRD1 P41143 3/20 0.36
OPRK1 P41145 3/20 0.36
MAPT P10636 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7387682 1.00 NPC1 (0.42) NPC1KMT2AMEN1RAB9ATDP1
SCHEMBL22454599 0.82 TDP1 (0.50) NPC1KMT2AMEN1RAB9ATDP1
SCHEMBL4727500 0.78 KMT2A (0.53) NPC1KMT2AMEN1RAB9ATDP1
SCHEMBL30764064 0.74 KMT2A (0.54) NPC1KMT2AMEN1RAB9ATDP1
SCHEMBL14282039 0.72 TDP1 (0.46) NPC1KMT2AMEN1RAB9ATDP1
SCHEMBL4521331 0.72 L3MBTL1 (0.47) NPC1KMT2AMEN1RAB9ATDP1
SCHEMBL1629317 0.72 TDP1 (0.56) NPC1KMT2AMEN1RAB9ATDP1
Hydrocinnamyl Alcohol SCHEMBL28142660 0.72 TAAR1 (0.51) NPC1KMT2ARAB9ATDP1TAAR1
Hydrocinnamyl Alcohol SCHEMBL28142659 0.71 TAAR1 (0.50) NPC1KMT2ARAB9ATDP1TAAR1
SCHEMBL4522760 0.70 SMN1; SMN2 (0.43) NPC1KMT2AMEN1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5409929-A Treating psychosis, dyskinesia THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-25 US disclosed
US-5216018-A Antidyskinetic agents DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-06-01 US disclosed